Company · CIK 0001434868 · SIC 2834 — Pharmaceutical Preparations
Esperion Therapeutics, Inc. · ESPR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2026 DForm 4 → | Jul 13, 4:06 pm EDT | Robert E. HoffmanDirector | 85,153 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:05 pm EDT | J Martin CarrollDirector | 177,523 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:05 pm EDT | Jay ShepardDirector | 164,472 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:05 pm EDT | Seth H. Z. FischerDirector | 141,023 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:04 pm EDT | John Craig ThompsonDirector | 79,873 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:04 pm EDT | John B. Harlow Jr.Chief Commercial Officer | 424,536 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:04 pm EDT | Benjamin LookerChief Legal Officer | 667,524 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:03 pm EDT | Benjamin HalladayChief Financial Officer | 705,410 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:03 pm EDT | Sheldon L. KoenigPresident and CEO, Director | 2,121,094 | — | — | 0 | — | |
| Jun 17, 2026 SForm 4 → | Jun 18, 4:06 pm EDT | Benjamin LookerChief Legal Officer | 11,824 | $3.16 | $37,305 | 667,524 | −1.74% | |
| Jun 17, 2026 SForm 4 → | Jun 18, 4:06 pm EDT | Sheldon L. KoenigPresident and CEO, Director | 53,588 | $3.16 | $169,070 | 2,119,111 | −2.47% | |
| Jun 17, 2026 SForm 4 → | Jun 18, 4:05 pm EDT | Benjamin HalladayChief Financial Officer | 10,773 | $3.15 | $33,989 | 702,829 | −1.51% | |
| Jan 4, 2019 PForm 4 → | Jan 7, 5:10 pm EST | Target N Biotech V +110% Owner | 80,000 | $41.29 | $3,303,256 | 3,472,964 | +2.36% | plan? |
| Dec 24, 2018 PForm 4 → | Dec 26, 11:44 am EST | Target N Biotech V +110% Owner | 50,000 | $39.91 | $1,995,725 | 3,392,964 | +1.50% | plan? |
| Dec 17, 2018 PForm 4 → | Dec 19, 1:14 pm EST | Target N Biotech V +110% Owner | 60,000 | $47.73 | $2,864,070 | 3,342,964 | +1.83% | plan? |
| Nov 2, 2018 SForm 4 → | Nov 5, 7:56 pm EST | Boxer Capital, LLC +210% Owner | 100,000 | $56.38 | $5,638,343 | 1,101,250 | −8.32% | plan? |
| Nov 1, 2018 SForm 4 → | Nov 2, 5:00 pm EDT | Roger S NewtonDirector | 2,827 | $50.07 | $141,549 | 573,726 | −0.49% | plan? |
| Oct 16, 2018 SForm 4 → | Oct 18, 5:05 pm EDT | Roger S NewtonDirector | 22,173 | $50.02 | $1,108,997 | 576,553 | −3.70% | plan? |
| Aug 27, 2018 SForm 4 → | Aug 29, 4:56 pm EDT | Roger S NewtonDirector | 17,700 | $51.05 | $903,610 | 598,726 | −2.87% | plan? |
| Aug 17, 2018 SForm 4 → | Aug 22, 7:18 am EDT | Roger S NewtonDirector | 7,300 | $50.06 | $365,438 | 616,426 | −1.17% | plan? late |
| Aug 3, 2018 PForm 4 → | Aug 6, 3:23 pm EDT | Target N Biotech V +110% Owner | 50,000 | $46.14 | $2,306,970 | 3,282,964 | +1.55% | plan? |
| Jul 12, 2018 PForm 4 → | Jul 13, 11:45 am EDT | Target N Biotech V +110% Owner | 50,000 | $41.77 | $2,088,300 | 3,232,964 | +1.57% | plan? |
| Jun 29, 2018 PForm 4 → | Jul 3, 11:55 am EDT | Target N Biotech V +110% Owner | 50,000 | $39.48 | $1,973,805 | 3,182,964 | +1.60% | plan? |
| Jun 22, 2018 JForm 4 → | Jun 26, 5:06 pm EDT | Nicole VitulloDirector | 25,317 | — | — | 6,963 | — | plan? |
| Jun 21, 2018 PForm 4 → | Jun 25, 12:43 pm EDT | Target N Biotech V +110% Owner | 60,000 | $38.57 | $2,314,224 | 3,132,964 | +1.95% | plan? |
| Jun 7, 2018 PForm 4 → | Jun 11, 2:59 pm EDT | Target N Biotech V +110% Owner | 60,000 | $37.79 | $2,267,292 | 3,072,964 | +1.99% | plan? |
| Jun 6, 2018 JMForm 4 → | Jun 8, 5:08 pm EDT | Dov A Goldstein M.D.Director | 26,000 | $16.47 | $214,100 | 47 | — | plan? |
| Jun 5, 2018 PForm 4 → | Jun 7, 2:34 pm EDT | Target N Biotech V +110% Owner | 60,000 | $38.47 | $2,308,440 | 3,012,964 | +2.03% | plan? |
| May 18, 2018 PForm 4 → | May 22, 3:49 pm EDT | Target N Biotech V +110% Owner | 130,000 | $40.11 | $5,213,770 | 2,952,964 | +4.61% | plan? |
| Mar 29, 2018 SForm 4 → | Mar 29, 7:47 pm EDT | Roger S NewtonDirector | 15,956 | $71.87 | $1,146,713 | 623,726 | — | plan? |
| Mar 29, 2018 SForm 4 → | Mar 29, 7:47 pm EDT | Roger S NewtonDirector | 9,044 | $73.26 | $662,563 | 639,682 | −1.39% | plan? |
| Jan 31, 2018 MForm 4 → | Feb 1, 5:29 pm EST | Timothy M MaylebenPresident & CEO, Director | 4,549 | $1.17 | $5,325 | 46,163 | — | plan? |
| Jan 25, 2018 SForm 4 → | Jan 26, 5:24 pm EST | Nicole VitulloDirector | 11,674 | $71.79 | $838,076 | 15,329 | −43.2% | plan? |
| Jan 24, 2018 FJMForm 4 → | Jan 26, 5:24 pm EST | Nicole VitulloDirector | 945,811 | $12.74 | $995,717 | 3,177 | — | plan? |
| Jan 2, 2018 MForm 4 → | Jan 3, 6:01 pm EST | Richard BartramChief Financial Officer | 17,892 | $3.70 | $66,200 | 19,092 | — | plan? |
| Dec 29, 2017 FGMForm 4 → | Jan 22, 2018, 8:49 pm EST | Daniel JanneyDirector | 116,363 | $12.79 | $995,681 | 0 | — | plan? late |
| Dec 18, 2017 JMForm 4 → | Dec 20, 5:53 pm EST | Dov A Goldstein M.D.Director | 42,942 | $3.70 | $79,443 | 47 | — | plan? |
| Dec 12, 2017 FGMForm 4 → | Feb 9, 2018, 5:47 pm EST | Roger S NewtonDirector | 50,259 | $6.99 | $267,430 | 648,726 | — | plan? late |
| Dec 6, 2017 SForm 4 → | Dec 8, 4:14 pm EST | Nicole VitulloDirector | 9,326 | $53.85 | $502,205 | 25,927 | −26.5% | plan? |
| Dec 6, 2017 JForm 4 → | Dec 8, 4:14 pm EST | Nicole VitulloDirector | 367,406 | — | — | 2,472 | — | plan? |
| Dec 5, 2017 JForm 4 → | Dec 8, 4:42 pm EST | Dov A Goldstein M.D.Director | 38 | — | — | 47 | — | plan? late |
| Mar 21, 2017 SForm 4 → | Mar 23, 4:45 pm EDT | Daniel JanneyDirector | 350,000 | $45.80 | $16,029,263 | 1,359,967 | −20.5% | plan? |
| Mar 21, 2017 SForm 4 → | Mar 23, 4:37 pm EDT | Dov A Goldstein M.D.Director | 800,000 | $41.66 | $33,327,088 | 837,125 | −48.9% | plan? |
| Mar 21, 2017 PForm 4 → | Mar 22, 8:02 am EDT | Gilbert S OmennDirector | 1,000 | $42.26 | $42,260 | 1,000 | — | plan? |
| Nov 1, 2016 PForm 4 → | Nov 3, 5:58 pm EDT | Narendra D. LalwaniChief Operating Officer | 5,000 | $9.93 | $49,650 | 5,000 | — | plan? |
| Jul 5, 2016 PForm 4 → | Jul 7, 7:17 am EDT | Mark E McGovernDirector | 5,000 | $10.00 | $50,000 | 5,000 | — | plan? |
| May 4, 2016 PForm 4 → | May 5, 7:33 am EDT | Timothy M MaylebenPresident & CEO, Director | 7,000 | $14.85 | $103,950 | 41,614 | +20.2% | plan? |
| Mar 1, 2016 PForm 4 → | Mar 2, 7:23 am EST | Gilbert S OmennDirector | 5,000 | $15.28 | $76,400 | 10,000 | +100% | plan? |
| Jan 27, 2016 PForm 4 → | Jan 28, 6:22 pm EST | Timothy M MaylebenPresident & CEO, Director | 3,600 | $15.88 | $57,168 | 34,614 | +11.6% | plan? |
| Jan 15, 2016 PForm 4 → | Jan 19, 7:16 am EST | Timothy M MaylebenPresident & CEO, Director | 7,200 | $14.08 | $101,376 | 31,014 | +30.2% | plan? |
| Aug 19, 2015 AForm 4 → | Aug 21, 4:02 pm EDT | Mary McGowanChief Medical Officer | 15,000 | — | — | 15,000 | — | plan? |
| Apr 28, 2015 JForm 4 → | Apr 30, 4:26 pm EDT | Dov A Goldstein M.D.Director | 199,991 | — | — | 1,637,125 | — | plan? |
| Apr 23, 2015 SForm 4 → | Apr 27, 6:33 pm EDT | Aisling Capital II LP +510% Owner | 217,469 | $108.22 | $23,534,373 | 1,837,125 | −10.6% | plan? |
| Apr 23, 2015 SForm 4 → | Apr 27, 6:32 pm EDT | Dov A Goldstein M.D.Director | 217,469 | $108.22 | $23,534,373 | 1,837,125 | −10.6% | plan? |
| Mar 20, 2015 JForm 4 → | Mar 24, 6:52 pm EDT | Parters Vii L P Domain +610% Owner | 350,000 | — | — | 2,216,935 | — | plan? |
| Mar 19, 2015 SForm 4 → | Mar 23, 4:06 pm EDT | Patrick G EnrightDirector | 500,000 | $111.66 | $55,831,597 | 18,361 | −96.5% | plan? |
| Feb 18, 2015 JForm 4 → | Feb 20, 5:03 pm EST | Alta Partners VIII, L.P.10% Owner | 842,222 | — | — | 1,709,967 | — | plan? |
| Sep 3, 2013 GForm 5 → | Feb 17, 2015, 4:27 pm EST | Timothy M MaylebenPresident & CEO, Director | 5,000 | — | — | 23,814 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2026 DForm 4 → | Jul 13, 4:06 pm EDT | Robert E. HoffmanDirector | 47,040 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:05 pm EDT | J Martin CarrollDirector | 97,500 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:05 pm EDT | Jay ShepardDirector | 97,500 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:05 pm EDT | Seth H. Z. FischerDirector | 97,500 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:04 pm EDT | John Craig ThompsonDirector | 40,000 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:04 pm EDT | Benjamin LookerChief Legal Officer | 620,230 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:03 pm EDT | Benjamin HalladayChief Financial Officer | 634,270 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:03 pm EDT | Sheldon L. KoenigPresident and CEO, Director | 2,042,460 | — | — | 0 | — | |
| Nov 28, 2018 AForm 4 → | Nov 30, 5:18 pm EST | Richard BartramChief Financial Officer | 12,000 | — | — | 12,000 | — | |
| Nov 28, 2018 AForm 4 → | Nov 30, 5:17 pm EST | Narendra D. LalwaniChief Operating Officer | 8,000 | — | — | 8,000 | — | |
| Nov 28, 2018 AForm 4 → | Nov 30, 5:15 pm EST | Timothy M MaylebenPresident & CEO, Director | 110,000 | — | — | 110,000 | — | |
| Jun 6, 2018 MForm 4 → | Jun 8, 5:08 pm EDT | Dov A Goldstein M.D.Director | 13,000 | — | — | 0 | — | |
| May 24, 2018 AForm 4 → | May 29, 4:34 pm EDT | Jay ShepardDirector | 18,700 | — | — | 18,700 | — | |
| May 23, 2018 AForm 4 → | May 25, 4:18 pm EDT | Scott BraunsteinDirector | 10,100 | — | — | 10,100 | — | |
| May 23, 2018 AForm 4 → | May 25, 4:18 pm EDT | Dov A Goldstein M.D.Director | 10,100 | — | — | 10,100 | — | |
| May 23, 2018 AForm 4 → | May 25, 4:17 pm EDT | Antonio M Jr Md D Phil GottoDirector | 10,100 | — | — | 10,100 | — | |
| May 23, 2018 AForm 4 → | May 25, 4:17 pm EDT | Daniel JanneyDirector | 10,100 | — | — | 10,100 | — | |
| May 23, 2018 AForm 4 → | May 25, 4:17 pm EDT | Mark E McGovernDirector | 10,100 | — | — | 10,100 | — | |
| May 23, 2018 AForm 4 → | May 25, 4:16 pm EDT | Roger S NewtonDirector | 10,100 | — | — | 10,100 | — | |
| May 23, 2018 AForm 4 → | May 25, 4:15 pm EDT | Jeffrey BerkowitzDirector | 4,427 | — | — | 4,427 | — | |
| May 23, 2018 AForm 4 → | May 25, 4:11 pm EDT | Nicole VitulloDirector | 10,100 | — | — | 10,100 | — | |
| Feb 22, 2018 AForm 4 → | Feb 23, 4:40 pm EST | Jeffrey BerkowitzDirector | 25,000 | — | — | 25,000 | — | |
| Feb 7, 2018 MForm 4 → | Feb 9, 5:47 pm EST | Roger S NewtonDirector | 34,651 | — | — | 0 | — | |
| Jan 31, 2018 MForm 4 → | Feb 1, 5:29 pm EST | Timothy M MaylebenPresident & CEO, Director | 4,549 | — | — | 0 | — | |
| Jan 24, 2018 MForm 4 → | Jan 26, 5:24 pm EST | Nicole VitulloDirector | 71,235 | — | — | 0 | — | |
| Jan 18, 2018 MForm 4 → | Jan 22, 8:49 pm EST | Daniel JanneyDirector | 71,237 | — | — | 0 | — | |
| Jan 2, 2018 AMForm 4 → | Jan 3, 6:01 pm EST | Richard BartramChief Financial Officer | 56,392 | — | — | 0 | — | |
| Jan 2, 2018 AForm 4 → | Jan 3, 6:01 pm EST | Narendra D. LalwaniChief Operating Officer | 36,000 | — | — | 36,000 | — | |
| Jan 2, 2018 AForm 4 → | Jan 3, 6:00 pm EST | Timothy M MaylebenPresident & CEO, Director | 107,000 | — | — | 107,000 | — | |
| Dec 18, 2017 MForm 4 → | Dec 20, 5:53 pm EST | Dov A Goldstein M.D.Director | 21,471 | — | — | 0 | — | |
| Apr 17, 2017 AForm 4 → | Apr 19, 9:00 pm EDT | Dov A Goldstein M.D.Director | 14,000 | — | — | 14,000 | — | |
| Apr 17, 2017 AForm 4 → | Apr 19, 4:52 pm EDT | Nicole VitulloDirector, 10% Owner | 14,000 | — | — | 14,000 | — | |
| Apr 17, 2017 AForm 4 → | Apr 19, 6:50 am EDT | Mark E McGovernDirector | 14,000 | — | — | 14,000 | — | |
| Apr 17, 2017 AForm 4 → | Apr 19, 6:50 am EDT | Gilbert S OmennDirector | 14,000 | — | — | 14,000 | — | |
| Apr 17, 2017 AForm 4 → | Apr 19, 6:49 am EDT | Daniel JanneyDirector | 14,000 | — | — | 14,000 | — | |
| Apr 17, 2017 AForm 4 → | Apr 19, 6:49 am EDT | Roger S NewtonDirector | 14,000 | — | — | 14,000 | — | |
| Apr 17, 2017 AForm 4 → | Apr 19, 6:49 am EDT | Antonio M Jr Md D Phil GottoDirector | 14,000 | — | — | 14,000 | — | |
| Apr 17, 2017 AForm 4 → | Apr 19, 6:49 am EDT | Scott BraunsteinDirector | 14,000 | — | — | 14,000 | — | |
| Feb 21, 2017 AForm 4 → | Feb 22, 6:48 pm EST | Narendra D. LalwaniChief Operating Officer | 10,800 | — | — | 10,800 | — | |
| Feb 21, 2017 AForm 4 → | Feb 22, 6:48 pm EST | Mary McGowanChief Medical Officer | 140,000 | — | — | 140,000 | — | |
| Feb 21, 2017 AForm 4 → | Feb 22, 6:48 pm EST | Timothy M MaylebenPresident & CEO, Director | 171,100 | — | — | 171,100 | — | |
| Jan 3, 2017 AForm 4 → | Jan 3, 6:43 pm EST | Timothy M MaylebenPresident & CEO, Director | 140,000 | — | — | 140,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 3, 6:42 pm EST | Narendra D. LalwaniChief Operating Officer | 55,000 | — | — | 55,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 3, 6:42 pm EST | Mary McGowanChief Medical Officer | 50,000 | — | — | 50,000 | — | |
| Jun 9, 2016 AForm 4 → | Jun 13, 4:53 pm EDT | Nicole VitulloDirector, 10% Owner | 8,000 | — | — | 8,000 | — | |
| Jun 9, 2016 AForm 4 → | Jun 10, 5:59 pm EDT | Scott BraunsteinDirector | 8,000 | — | — | 8,000 | — | |
| Jun 9, 2016 AForm 4 → | Jun 10, 5:58 pm EDT | Antonio M Jr Md D Phil GottoDirector | 8,000 | — | — | 8,000 | — | |
| Jun 9, 2016 AForm 4 → | Jun 10, 5:57 pm EDT | Daniel JanneyDirector | 8,000 | — | — | 8,000 | — | |
| Jun 9, 2016 AForm 4 → | Jun 10, 5:57 pm EDT | Mark E McGovernDirector | 8,000 | — | — | 8,000 | — | |
| Jun 9, 2016 AForm 4 → | Jun 10, 5:56 pm EDT | Gilbert S OmennDirector | 8,000 | — | — | 8,000 | — | |
| Jun 9, 2016 AForm 4 → | Jun 10, 4:32 pm EDT | Dov A Goldstein M.D.Director | 8,000 | — | — | 8,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 5, 5:38 pm EST | Mary McGowanChief Medical Officer | 15,000 | — | — | 15,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 5, 5:37 pm EST | Narendra D. LalwaniChief Operating Officer | 15,000 | — | — | 15,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 5, 5:36 pm EST | Timothy M MaylebenPresident & CEO, Director | 30,000 | — | — | 22 | — | |
| Aug 19, 2015 AForm 4 → | Aug 21, 4:02 pm EDT | Scott BraunsteinDirector | 20,000 | — | — | 20,000 | — | |
| Aug 19, 2015 AForm 4 → | Aug 21, 4:02 pm EDT | Mary McGowanChief Medical Officer | 210,000 | — | — | 210,000 | — | |
| May 14, 2015 AForm 4 → | May 18, 5:27 pm EDT | Antonio M Jr Md D Phil GottoDirector | 8,000 | — | — | 8,000 | — | |
| May 14, 2015 AForm 4 → | May 18, 5:26 pm EDT | Daniel JanneyDirector | 8,000 | — | — | 8,000 | — | |
| May 14, 2015 AForm 4 → | May 18, 5:26 pm EDT | Patrick G EnrightDirector | 8,000 | — | — | 8,000 | — | |
| May 14, 2015 AForm 4 → | May 18, 5:25 pm EDT | Mark E McGovernDirector | 8,000 | — | — | 8,000 | — | |
| May 14, 2015 AForm 4 → | May 18, 5:25 pm EDT | Gilbert S OmennDirector | 8,000 | — | — | 8,000 | — | |
| May 14, 2015 AForm 4 → | May 18, 5:19 pm EDT | Dov A Goldstein M.D.Director | 8,000 | — | — | 8,000 | — | |
| May 14, 2015 AForm 4 → | May 15, 12:41 pm EDT | Nicole VitulloDirector, 10% Owner | 8,000 | — | — | 8,000 | — | |
| Mar 18, 2015 AForm 4 → | Mar 20, 6:18 pm EDT | Roger S NewtonExecutive Chairman & CSO, Director | 8,000 | — | — | 8,000 | — | |
| Mar 18, 2015 AForm 4 → | Mar 20, 6:18 pm EDT | Timothy M MaylebenPresident & CEO, Director | 36,800 | — | — | 36,800 | — | |
| Mar 18, 2015 AForm 4 → | Mar 20, 6:16 pm EDT | Narendra D. LalwaniChief Operating Officer | 20,000 | — | — | 20,000 | — | |
| Jan 2, 2015 AForm 4 → | Jan 6, 4:44 pm EST | Roger S NewtonExecutive Chairman & CSO, Director | 20,000 | — | — | 20,000 | — | |
| Jan 2, 2015 AForm 4 → | Jan 6, 4:43 pm EST | Narendra D. LalwaniChief Operating Officer | 50,000 | — | — | 50,000 | — | |
| Jan 2, 2015 AForm 4 → | Jan 6, 4:43 pm EST | Timothy M MaylebenPresident & CEO, Director | 92,000 | — | — | 92,000 | — |